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Abstract—The cardiovascular hormone atrial natriuretic peptide (ANP) exerts anti-inflammatory effects on tumor necrosis
factor-–activated endothelial cells by inducing mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1). The
underlying mechanisms are as yet unknown. We aimed to elucidate the signaling pathways leading to an induction of
MKP-1 by ANP in primary human endothelial cells. By using antioxidants, generation of reactive oxygen species (ROS)
was shown to be crucially involved in MKP-1 upregulation. ANP was found to increase ROS formation in cultured cells
as well as in the endothelium of intact rat lung vessels. We applied NAD(P)H oxidase (Nox) inhibitors (apocynin and
gp91ds-tat) and revealed this enzyme complex to be crucial for superoxide generation and MKP-1 expression.
Moreover, by performing Nox2/4 antisense experiments, we identified Nox2 as the critically involved Nox homologue.
Pull-down assays and confocal microscopy showed that ANP activates the small Rho-GTPase Rac1. Transfection of a
dominant-negative (RacN17) and constitutively active Rac1 mutant (RacV12) indicated that ANP-induced superoxide
generation and MKP-1 expression are mediated via Rac1 activation. ANP-evoked production of superoxide was found
to activate c-Jun N-terminal kinase (JNK). Using specific inhibitors, we linked ANP-induced JNK activation to MKP-1
expression and excluded an involvement of protein kinase C, extracellular signal-regulated kinase, and p38 MAPK.
MKP-1 induction was shown to depend on activation of the transcription factor activator protein-1 (AP-1) by using
electrophoretic mobility shift assay and AP-1 decoys. In summary, our work provides insights into the mechanisms by
which ANP induces MKP-1 and shows that ANP is a novel endogenous activator of endothelial Rac1 and Nox/Nox2.
(Circ Res. 2005;96:43-53.)
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The cardiovascular hormone atrial natriuretic peptide(ANP) plays an important and well-investigated role in
the cardiovascular system by participation in blood pressure
regulation.1 ANP mainly acts through binding to the guanylyl
cyclase–coupled natriuretic peptide receptor-A (NPR-A),
leading to generation of the second messenger cGMP.1 ANP
also binds to NPR-C, which generally acts as a clearance
receptor1 but is also able to mediate an inhibition of adenylyl
cyclase activity and activation of phospholipase C.2
A growing number of studies highlight the profound
anti-inflammatory and vasoprotective actions exerted by
ANP.3,4 In this context, we revealed recently that ANP is able
to induce mitogen-activated protein kinase (MAPK)
phosphatase-1 (MKP-1) in cultured endothelial cells (ECs).5
MKP-1 inhibits tumor necrosis factor- (TNF-)–induced
p38 MAPK activation, thus leading to a reduction of stress
fiber formation,5 endothelial permeability,5 and expression of
monocyte chemoattractant protein-1.6 In summary, ANP
protects TNF-–activated ECs against structural and func-
tional changes by inducing MKP-1.
MAPKs play a crucial role in a great variety of intra-
cellular signaling cascades. Pathways of MAPK activation
are quite well known compared with the mechanisms of
their inactivation, which represent equally important steps
in signal transduction. Dual specificity MAPK phospha-
tases such as MKP-1 inactivate MAPK by dephosphoryla-
tion of the two critical MAPK residues accountable for
their activity. MKP-1 is constitutively expressed at a very
low level and underlies a tight and rapid transcriptional
induction by different stimuli.7 Little is known about the
signaling events leading to an MKP-1 induction besides
reports describing that reactive oxygen species (ROS)8,9
and different kinases (MAPK and protein kinase C
[PKC])10 –13 might be involved.
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For several decades, ROS were considered toxic byprod-
ucts of metabolic processes being able to damage cellular
components. Many diseases have been implicated with oxi-
dative stress, but in the last years, more and more studies
revealed that ROS not only take part in pathological condi-
tions but also as second messengers in cell signaling pro-
cesses. The prototypical, well-known phagocyte NAD(P)H
oxidase (Nox), a superoxide-producing enzyme complex,
consists of six components: gp91phox/Nox2, p22phox, p47phox,
p67phox, p40phox, and Rac, which are all known to be present in
ECs.14 The low amounts of superoxide produced by endothe-
lial Nox can stimulate a variety of transcription factors and
signaling cascades without altering the cellular redox state.15
In recent years, gp91phox/Nox2 homologues (Nox1–Nox5)
have been discovered. Besides gp91phox/Nox2, Nox1 and
Nox4 have been shown recently to be expressed in ECs,16
suggesting that different types of Noxes coexist in the
endothelium. The physiological significance of this fact is as
yet only poorly investigated.
Because MKP-1 induction accounts for the above-
mentioned protective effects of ANP on ECs,5,6 we were
interested in the molecular mechanisms underlying MKP-1
upregulation. We hypothesized that ANP-induced generation
of ROS is an early event in the signal transduction pathway
upregulating MKP-1 and aimed to characterize the enzymatic
source of ROS generation. Moreover, we hypothesized that a
ROS-activated kinase and transcription factor could be re-
sponsible for the increased MKP-1 expression.
Materials and Methods
Materials
Cell culture supplies were from PAN Biotech. Rat ANP was from
Bachem and (Cys 18)-atrial natriuretic factor (4–18) amide (rat)
from Saxon Biochemicals. 8-Br-cGMP, SB203580, calphostin C,
PD98059, phorbol-12-myristate-13-acetate (PMA), and SP600125
were from Calbiochem. GTPS was from Roche. gp91ds-tat was
provided by Dr P. Pagano (Detroit, Mich). Anti–MKP-1 and anti-
Nox4 antibodies were from Santa Cruz Biotechnology, anti–c-Jun
N-terminal kinase (JNK) and anti–phospho-JNK from Cell Signal-
ing, and anti-Rac from Upstate Biotechnology. Anti-Nox2 was
provided by Dr D. Roos (Amsterdam, the Netherlands). Alex-
aFluor488 goat anti-mouse, dihydrofluorescein diacetate, and dihy-
drodichlorofluorescein diacetate were from Molecular Probes.
Horseradish peroxidase–conjugated goat anti-rabbit and donkey
anti-goat were from Dianova and goat anti-mouse from Cell Signal-
ing. Activator protein-1 (AP-1) decoy/scrambled decoy and Nox2/4
antisense/sense phosphorothioate oligodesoxynucleotides and prim-
ers for MKP-1 and Nox1–Nox5 were from MWG Biotech or
biomers.net. All other substances were from Sigma-Aldrich.
Cell Culture
Human umbilical vein ECs (HUVECs) were prepared, cultured,
characterized, and used for studies as described.5 Human microvas-
cular ECs (HMECs), a cell line known to retain endothelial pheno-
typic and functional characteristics,17 were from Centers for Disease
Control and Prevention (Atlanta, Ga). HMECs were cultured in EC
growth medium (Promocell).
Western Blot Analysis
In Vitro Samples
Immunoblotting was performed as described.5 All experiments were
performed in duplicates or triplicates, and one representative blot of
two to four independent experiments is shown.
In Vivo Samples
In anesthetized Sprague-Dawley rats, a bolus of ANP (n3) or an
equivalent volume of NaCl (n3) was injected via a central venous
catheter. ANP dosage was calculated to reach a blood concentration
of 1 mol/L. Sixty minutes after bolus administration, lungs were
excised and cryopreserved in liquid nitrogen. Lung tissue protein
was extracted, and immunoblotting was performed as described.5
Detection of mRNA
RNA isolation, RT-PCR, agarose gel electrophoresis, and ethidium
bromide staining were performed as described.5 Primers for MKP-1:
5-GCTGTGCAGCAACAGTC-3 and 5-TACCTTATGAGG-
ACTAATCG-3; Nox1: 5-TGGCTAAATCCCATCCAGTC-3 and
5-AGTGGGAGTCACGATCATCC-3; Nox2: 5-TGGATA-
GTGGGTCCCATGTT-3 and 5-GCTTATCACAGCCACAA-
GCA-3; Nox3: 5-CCAGGGCAGTACATCTTGGT-3 and 5-
CTGTGCCTCACTGCATTTGT-3; Nox4: 5-TGTTGGATGACTGG-
AAACCA-3 and 5-TGGGTCCACAACAGAAAACA-3; and
Nox5: 5-CTACGTGGTAGTGGGGCTGT-3 and 5-AACAA-
GATTCCAG-GCACCAG-3.
Electrophoretic Mobility Shift Assay
Nuclear extracts were prepared and electrophoretic mobility shift
assay (EMSA) was performed as described.18 SuperFect transfection
reagent (Qiagen) was used to transfect AP-1 decoy (5-
cgctTGATGACTC-AGCCggaa-3) and scrambled decoy (5-
cgctTGATGACTTGGCCggaa-3; (lower case letter: phosphorothio-
ate backbone). One representative image of 2 to 3 independent
experiments is shown.
Detection of ROS in Cell Culture
Cells were loaded with 20 mol/L dihydrofluorescein diacetate for
20 minutes. Fluorescence measurements (excitation, 485 nm; emis-
sion, 535 nm) were taken 30 minutes after treatment (except for ANP
time course). Data were calculated as percent increase/decrease of
fluorescence values of untreated cells. For each experiment, two to
four independent cell preparations were used with at least six parallel
samples.
Isolated-Perfused Rat Lung Preparation and In
Situ Fluorescence Microscopy
Isolated-perfused rat (Sprague-Dawley) lung preparation was per-
formed as described.19,20 ROS production was determined in situ by
digital fluorescence imaging of lung capillary ECs loaded with
dihydrodichlorofluorescein diacetate,21 which was infused into pul-
monary venular capillaries using a venous microcatheter.19,20 The
procedure is proven for selective loading of fluorescent dyes to ECs.
Fluorescence was excited at 488 nm. Emission was collected by a
CCD camera and subjected to digital image analysis (TILL Photon-
ics). Images of single subpleural capillaries were obtained in
5-second intervals and were corrected for background as determined
over alveolar spaces. Capillaries were viewed at a focal plane
corresponding to their maximum diameter (12 to 25 m).
Assay of Rac1 Activity
The affinity precipitation assay detecting active Rac1 uses the
p21-binding domain (PBD) of the Rac1 target p21-activated kinase
1 fused to glutathione S-transferase (GST) to isolate a complex
containing GST-PBD bound to active Rac1 (Rac1-GTP). The plas-
mid encoding the GST-PBD fusion protein was provided by Dr U.
Knaus (La Jolla, Calif). GST-PBD was expressed in Escherichia
coli, purified, and bound to glutathione Sepharose beads (Amer-
sham). Rac1 pull-down assays were performed as described.22
Nox2/4 Antisense Experiments
HUVECs were transfected with Nox2 antisense (5-cctcatTCACAGCG-
cagtt-3), Nox4 antisense (5-ggacaCAGCCATGccgcc-3), or the respec-
tive sense oligos (lower case letter: phosphorothioate backbone) by using
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jetPEI (Polyplus-Transfection). Experiments were started 24 to 48 hours
after transfection.
Confocal Laser Scanning Microscopy
HUVECs were cultured on collagen-coated glass cover slips, treated,
fixed with 4% formaldehyde, permeabilized with 0.2% Triton
X-100, and incubated with primary and secondary antibody for 1
hour each. Images were obtained with Zeiss LSM 510 META.
Plasmid Constructs and Transfection of HMECs
The expression vectors for myc-tagged Rac1 were cloned by
excision of the EcoRI fragment from the constructs RacN17pc-myc
and RacV12pc-myc and ligation into the EcoRI site of pcDNA3.1.
HMECs were transfected with the RacN17-, RacV12-construct, or
control plasmid pcDNA3.1 by using SuperFect transfection reagent
(Qiagen).
Statistical Analysis
Data are expressed as meanSEM. Statistical analysis was per-
formed with GraphPad Prism 3.03. A 5% significance level was used
(P0.05). For ROS measurement in cultured cells, one-way
ANOVA followed by Tukey’s post test was used. For ROS mea-
surement in rat lung ECs, data of independent groups were compared
by Mann–Whitney U test.
Results
ANP Induces MKP-1 Expression
via cGMP/NPR-A
ANP rapidly increased endothelial MKP-1 protein expression
with a maximum at 30 minutes (Figure 1A). Because ANP
may act via two different receptors, we investigated the
receptor specificity of this effect. 8-Br-cGMP, a cell-
permeable analogue of the NPR-A–dependent second mes-
senger of ANP, mimicked the effect of ANP. MKP-1 levels
were not altered by cANF, a specific ligand of NPR-C (Figure
1B). These data suggest that the induction of MKP-1 by ANP
is mediated via cGMP/NPR-A without participation of
NPR-C. Inhibition of protein biosynthesis by cycloheximide
completely suppressed ANP-induced MKP-1 induction after
30 minutes (Figure 1C), indicating that ANP activates MKP-1
protein de novo synthesis within 30 minutes.
ANP Induces ROS, Which Are Responsible for
MKP-1 Upregulation
We measured intracellular ROS generation by loading
HUVECs with an ROS-sensitive fluorescent dye. ANP
treatment augmented ROS production with a maximum
dye fluorescence at 30 minutes (Figure 2A). The con-
centration dependency of this effect is shown in Figure 2B.
We also tested whether 8-Br-cGMP and cANF affect ROS
generation. cANF did not significantly change ROS levels,
whereas 8-Br-cGMP clearly induced ROS production (Fig-
ure 2C), indicating that ANP induces ROS production via
cGMP/NPR-A. We aimed to causally link ANP-induced
ROS generation and MKP-1 expression. Treatment of
HUVECs with tiron (superoxide scavenger), ebselen (scav-
enger of peroxynitrite and peroxides), and N-acetyl-L-
cysteine (thiol-based antioxidant) abrogated ANP-induced
MKP-1 expression (Figure 2D). We also confirmed that
exogenous administration of an oxidant (hydrogen perox-
ide [H2O2]) increases MKP-1 levels (Figure 2E).
Involvement of Nox/Nox2
We intended to clarify whether Nox is involved in ANP-
induced ROS generation. Scavenging superoxide by a
cell-permeable form of superoxide dismutase (SOD) (pe-
gylated [PEG]-SOD) and inhibiting Nox by diphenylenei-
odonium (DPI; nonspecific Nox inhibitor) completely
abrogated the ANP-induced fluorescence signal and
MKP-1 induction (Figure 3A and 3B). The highly specific
Nox inhibitor peptide gp91ds-tat (inhibits interaction of
Nox1/2/4 and p47phox)23 abolished the increase of ROS by
ANP (Figure 3C), and apocynin (specific Nox inhibitor)
reduced the ability of ANP to induce MKP-1 (Figure 3D).
The treatment of HUVECs with SOD, catalase (degrades
H2O2), and PEG-catalase did not influence ROS generation
or MKP-1 induction by ANP (see the online data supple-
ment, available at http://circres.ahajournals.org), pointing
to intracellularly produced superoxide as the crucially
involved ROS. Furthermore, we intended to clarify which
Nox2 homologue (Nox1–5) is responsible for ROS pro-
duction and subsequent MKP-1 induction. We examined
the mRNA expression of Nox1–Nox5: Nox2 and Nox4
were found to be expressed (Figure 3E) in HUVECs and
HMECs. Using a Nox2/4 antisense approach, we revealed
that Nox2 (Figure 3F) but not Nox4 (Figure 3G) is crucial
for the ANP-induced ROS generation and MKP-1
upregulation.
Rac1 Involvement
The small Rho-GTPase Rac plays an important role in the
activation of phagocyte-type Nox and might also be involved
Figure 1. Effect of ANP, 8-Br-cGMP, cANF, and cycloheximide
on MKP-1 protein expression. Control cells (Co) were left
untreated. A, HUVECs were treated with ANP (1 mol/L) as indi-
cated. B, Cells were treated with ANP (1 mol/L), 8-Br-cGMP,
or cANF for 60 minutes. C, HUVECs were treated with ANP
(1 mol/L), as indicated in the presence of cycloheximide (10
g/mL, 30 minutes before ANP). MKP-1 protein expression was
determined by Western blot analysis.
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in the activation of endothelial Nox.24 We performed Rac1
pull-down assays and found an increase of active Rac1 by
ANP with a maximum at 2 to 5 minutes (Figure 4A). Further,
we investigated Rac1 translocation by confocal microscopy.
ANP mimicked the Rac1 translocation observed by treating
HUVECs with the known Rac1 activator PMA25 (Figure 4B).
To causally link Rac1 activation to the effects of ANP on
superoxide generation and MKP-1, we transfected HMECs
(because of difficulties in transfecting plasmids into primary
HUVECs26) with a dominant-negative (RacN17) and a con-
stitutively active (RacV12) Rac1 mutant. ANP-induced su-
peroxide production and MKP-1 expression were abolished
by RacN17, whereas RacV12 mimicked the effects of ANP
(Figure 4C), indicating that Rac1 is crucially involved in the
generation of superoxide and expression of MKP-1 after ANP
treatment.
MKP-1 Induction Is Not Mediated by PKC,
Extracellular Signal-Regulated Kinase, or p38 MAPK
PKC and the MAPK extracellular signal-regulated kinase
(ERK), p38, and JNK have been communicated to mediate
MKP-1 induction after diverse stimuli.10 –13 We treated
HUVECs with inhibitors of these kinases. The inhibitors
calphostin C for PKC (Figure 5A), PD98059 for the ERK
pathway (Figure 5B), and SB203580 for p38 MAPK (Figure
5C) did not affect ANP-induced MKP-1 expression, suggest-
ing that PKC, ERK, and p38 MAPK do not mediate MKP-1
induction by ANP.
Figure 2. ROS generation in HUVECs. A, ANP (1 mol/L) time course. B, Concentration-dependent action of ANP. C, Effect of 8-Br-
cGMP and cANF (*P0.05 vs control [Co]). D and E, Involvement of ROS in the upregulation of MKP-1. D, HUVECs were preincubated
with the antioxidants tiron (Ti; 10 mmol/L), ebselen (Eb; 40 mol/L), and N-acetyl-L-cysteine (NAC; 10 mmol/L) for 60 minutes before
adding ANP (1 mol/L, 60 minutes). E, Cells were left untreated (Co) or were treated with H2O2 (50 mol/L). MKP-1 protein expression
was determined by Western blot analysis.
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Figure 3. Involvement of Nox. A through D, HUVECs were pretreated with PEG-SOD (300 U/mL; 60 minutes), DPI (10 mol/L; 60 minutes), gp91ds-
tat (or scrambled scramb-tat; 100 mol/L; 30 minutes), or apocynin (0.5 mmol/L; 30 minutes) before ANP (1 mol/L). ROS generation was mea-
sured and MKP-1 protein expression (60 minutes ANP) was determined by Western blot analysis (*P0.05 vs Co; †P0.05 vs ANP). E, Expression
of Nox1–Nox5 mRNA in untreated HMECs and HUVECs was investigated by RT-PCR. Nox2/4 antisense experiments. F and G, HUVECs were
transfected with Nox2 or Nox4 antisense oligos. Nox2/4 downregulation is shown in the top panel. Cells were treated with ANP (1 mol/L), and
ROS generation was measured. Nox2, Nox4, and MKP-1 protein expression (60 minutes ANP) was determined by Western blot analysis (*P0.05
vs Co; †P0.05 vs ANP).
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Role of JNK and AP-1
The JNK inhibitor SP600125 abolished the ANP-induced
expression of MKP-1 protein and mRNA (Figure 6A and 6B),
suggesting an involvement of JNK in MKP-1 upregulation by
ANP. Consistently, ANP increased the active form of JNK
(phospho-JNK) with a maximum at 5 minutes (Figure 6C).
Because we found that ANP induces superoxide generation,
we proved the role of superoxide in the activation of JNK by
ANP. The superoxide scavengers tiron and PEG-SOD de-
creased ANP-induced JNK phosphorylation (Figure 6D and
6E). Because the transcription factor AP-1 is an important
target of JNK, we assessed AP-1 DNA-binding activity after
treatment with ANP and SP600125. Inhibition of JNK com-
pletely blocked the ANP-induced activity of AP-1 (Figure
Figure 4. Involvement of Rac1. A, Pull-down assays of Rac1-GTP. HUVECs were treated with ANP (1 mol/L) as indicated. GTPS
serves as positive control (Co). Bottom panel shows uniformity of total Rac1 content. B, Confocal images of Rac1 translocation.
HUVECs were treated with ANP (1 mol/L) and PMA (1 mol/L) for the indicated times. Arrows show Rac1 translocation to the mem-
branes. C, ROS generation was measured, and MKP-1 protein expression was determined. HMECs were transfected with the control
plasmid pcDNA3.1, the dominant-negative (RacN17), or the constitutively active (RacV12) Rac1 mutant, and were treated with ANP
(1 mol/L) as indicated (*P0.05 vs untreated cells; †P0.05 vs ANP-treated cells).
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6F). To causally link AP-1 to the induction of MKP-1, we
used an AP-1 decoy approach.27 Figure 6G demonstrates the
functionality of the transfected AP-1 decoy. The decoy
completely abrogated the increase of MKP-1 expression by
ANP (Figure 6H). These results indicate that MKP-1 induc-
tion by ANP is mediated via the JNK/AP-1 pathway.
ROS Generation in Intact Blood Vessels
To clarify whether the ANP-induced ROS generation mea-
sured in cultured ECs is also relevant in vivo (ie, in intact
blood vessels), we loaded rat lung ECs in isolated perfused
organs with an ROS-sensitive fluorescent dye. Intracellular
ROS generation was measured by in situ fluorescence mi-
croscopy. Resting ECs showed no alteration of dye fluores-
cence over 2 hours (Figure 7A), but ANP treatment increased
endothelial ROS formation (Figure 7B). This increase was
abolished by addition of DPI (Figure 7C and 7D). Impor-
tantly, we proved that ANP causes an increase in MKP-1
protein levels in vivo (ie, in the rat lung [Figure 7E]).
Together, our findings demonstrate that ANP induces ROS
not only in cultured ECs but also in the endothelium of intact
rat lung vessels and that MKP-1 is also induced by ANP in
vivo.
Discussion
In recent years, more and more studies emerged that present
profound data suggesting a pivotal role for MKP-1 in differ-
ent signaling pathways leading to anti-inflammatory,28 anti-
atherogenic,29 and cytoprotective30 actions. Accordingly, we
have shown recently that ANP exerts its anti-inflammatory
effects on TNF-–activated ECs via induction of MKP-1.5,6
Therefore, it seemed of special interest to obtain information
about the as yet completely unknown signaling mechanisms
involved in MKP-1 induction by ANP in ECs. We revealed
that ANP activated Rac1, leading to the production of
superoxide by a Nox2-containing Nox. Superoxide activates
the JNK/AP-1 pathway, resulting in transcriptional upregula-
tion of MKP-1. The proposed pathway is schematically
depicted in Figure 8.
MKP-1 induction was found to be mediated via NPR-A/
cGMP. Supporting this finding, cGMP-dependent induction
of MKP-1 was described in vascular smooth muscle cells
(VSMCs) and renal cells.8,31 Blockade of protein biosynthesis
did not inhibit the early increase of MKP-1 at 15 minutes,
suggesting that other effects than transcriptional upregulation
are responsible for this early induction. MKP-1 is known to
be rapidly degraded by the ubiquitin/proteasome pathway.32 It
might be speculated that ANP interferes with MKP-1 catab-
olism, accounting for the early increase of MKP-1. However,
the increased MKP-1 protein levels at later time points
definitely represent newly synthesized protein.
We found that ANP concentration-dependently increases
ROS formation (Figure 8). This increase is mediated via
NPR-A/cGMP. Nothing has yet been known about the
potency of ANP to induce endothelial ROS. However, ANP
is known to induce ROS in macrophages33 and in renal cells,8
and cGMP was reported to induce ROS in cardiomyocytes.34
A causal link between ROS generation and MKP-1 induction
was established, and we corroborated the ability of ROS to
induce MKP-1 by exogenously supplying H2O2, which is
known to induce MKP-1 in VSMCs and epithelial cells.9,35
Most important, we found that these in vitro results were
approved by in situ ROS measurement in ECs of intact lung
vessels. Moreover, we confirmed that ANP induces MKP-1
not only in cell culture but also in the isolated perfused rat
lung, pointing to an in vivo relevance of our in vitro findings.
Nox was identified as the crucial ANP-induced ROS
source responsible for MKP-1 induction (Figure 8) by using
different inhibitors. Experiments with catalase and SOD (see
the online data supplement) corroborated that superoxide but
not H2O2 is the crucially involved oxidant species mediating
the effects of ANP. SOD converts superoxide to H2O2.
Interestingly, we did not observe an augmented MKP-1
induction during ANP/SOD treatment, although exogenously
supplied H2O2 leads to an upregulation of MKP-1. This might
be attributable to the fact that endothelial Nox produces only
low amounts of superoxide, which may consequently lead to
SOD-converted H2O2 levels unable to induce MKP-1. In
contrast, the exogenously supplied H2O2 amounts are incom-
parably higher.
The phagocyte-type Nox contains a transmembrane elec-
tron transport chain. Oxygen is reduced to superoxide in the
extracellular space or in phagocytic vacuoles.36 Neither the
precise structure nor the exact localization of functionally
active endothelial Noxes has yet been clarified. The question
arises whether endothelial Nox releases superoxide intracel-
lularly or extracellularly. Our data suggest an intracellular
superoxide release because the cell-permeable PEG-SOD
Figure 5. Role of PKC, ERK, and p38 MAPK. HUVECs were left
untreated (control [Co]), treated with ANP alone (1 mol/L; 60
minutes), in combination with the PKC inhibitor calphostin C
(CC; 100 nmol/L; A), the ERK pathway inhibitor PD98059 (PD;
10 mol/L; B), or the p38 MAPK inhibitor SB203580 (SB;
5 mol/L; C), or were treated with the respective inhibitor alone
(60 minutes). MKP-1 protein expression was determined by
Western blot analysis.
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Figure 6. Involvement of JNK. A, HUVECs were preincubated with the JNK inhibitor SP600125 (SP; 10 mol/L) 60 minutes before ANP (1 mol/L;
60 minutes). MKP-1 protein expression was determined by Western blot analysis. B, Cells were preincubated with SP (10 mol/L) 60 minutes
before ANP (1 mol/L; 30 minutes). MKP-1 and GAPDH mRNA expression was assessed by RT-PCR. C, HUVECs were treated with ANP
(1 mol/L) as indicated. D and E, HUVECs were left untreated, were treated with ANP alone (1 mol/L; 5 minutes) or in combination with the super-
oxide scavenger tiron (Ti; 10 mmol/L; 60 minutes pretreatment) or PEG-SOD (300 U/mL; 60 minutes pretreatment), or were treated with tiron or
PEG-SOD alone (60 minutes). Phospho-JNK Western blots were performed (top panels). Bottom panels show uniformity of total JNK content.
Involvement of AP-1. F, HUVECs were left untreated (control [Co]), treated with ANP (1 mol/L) or SP (10 mol/L) alone, or with a combination of
both (SP 60 minutes pretreatment). G and H, HUVECs were transfected with AP-1 decoy or scrambled decoy and were treated with ANP
(1 mol/L; 60 minutes; H). AP-1 DNA-binding activity was investigated by EMSA, and MKP-1 protein expression was determined by Western blot
analysis.
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Figure 7. ROS generation in intact rat lung blood vessels. Baseline fluorescence is shown in each panel. A, Regular HEPES buffer was
continuously infused over 120 minutes. B, ANP (1 mol/L) was infused for 60 minutes, followed by 60 minutes of buffer perfusion. C,
Vessels were pretreated with DPI (20 mol/L) for 20 minutes, followed by 60 minutes ANP and 60 minutes buffer perfusion. One repre-
sentative graph and image of five independent experiments is shown. D, Data of ANP-treated vs ANP- and DPI-treated cells of all five
experiments are shown as meansSEM (*P0.05 vs data from lungs treated with ANP alone). E, Rats were anesthesized, and NaCl
solution (control [Co]) or ANP (1 mol/L plasma concentration) was parenterally applied. After 1 hour, lungs were excised. Rat lung
lysates were investigated for MKP-1 protein expression by Western blot analysis.
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completely blocked the fluorescence signal, whereas only
extracellularly present SOD did not alter the signal.
Rac, a well-known component of the phagocyte-type Nox,
was revealed to be rapidly activated by ANP (Figure 8). The
precise role of Rac in endothelial Nox assembly and activa-
tion is not yet completely understood, and only few studies
suggest a role for Rac in Nox-derived endothelial ROS
generation.37,38 Therefore, it might be of special interest that
our results show that Rac1 plays a pivotal role in the
generation of superoxide and in the upregulation of MKP-1.
Rac1 is known to translocate to the plasma membrane during
activation,39 which could mean that Nox also is localized
there. However, the pure microscopic localization of Rac at
the plasma membrane does not allow any conclusions about
the direction of superoxide release (cytosolic versus
extracellular).
To clarify which Nox isoform is responsible for superoxide
production, we characterized the Nox spectrum expressed in
HUVECs and HMECs and found Nox2 and Nox4 mRNA and
protein to be present. Ago et al communicated similar
findings for HUVECs and rat aortic ECs,16 but they also
described an extremely low expression of Nox1, which we
could not confirm and which might be attributable to different
cell culture conditions or experimental settings. By using an
antisense approach, only Nox2 was found to be responsible
for ANP-induced superoxide generation and subsequent
MKP-1 induction (Figure 8). Interestingly, DPI and gp91ds-
tat reduced superoxide production below control levels. This
suggests a constitutive production of superoxide in resting
cells. DPI is known to inhibit several other ROS sources
(flavin-containing enzymes), which could in part account for
basal ROS/superoxide production. The fact that the inhibitor
peptide gp91ds-tat targets Nox2 and Nox4 suggests that
Nox4 might be a constitutively active Nox isoform responsi-
ble for basal levels of superoxide production because Nox2
but not Nox4 antisense reverses the effect of ANP. In
summary, we found that ANP-induced superoxide generation
and MKP-1 expression are mediated via Rac1 and a Nox2-
containing Nox.
Downstream of Nox2-mediated superoxide formation, we
causally linked JNK to the ANP-induced expression of
MKP-1 and excluded a role for PKC, ERK, and p38 MAPK.
Accordingly, numerous studies exist demonstrating that JNK
is regulated by ROS.40,41 The transcription factor AP-1 is a
central target of JNK. As reported previously by ourselves42
and confirmed in the present study, ANP induces AP-1
activity. This finding is supported by a study showing cGMP,
the second messenger of ANP, as an activator of AP-1.43 By
using AP-1 decoys, we could causally link the activation of
AP-1 to an upregulation of MKP-1. In conclusion, our data
suggest that JNK-mediated AP-1 activation is crucially in-
volved in MKP-1 induction by ANP.
In the present study, we, for the first time, provide evidence
that Nox/Nox2 is activated by ANP in human ECs. It should
be noted that other known endogenous Nox activators, such
as thrombin, angiotensin II, or TNF-,15 are generally re-
garded as proinflammatory agents. Therefore, it seems of
special interest that the functional outcome of Nox2 activa-
tion by ANP is the induction of MKP-1, a protein that exerts
cytoprotective effects on ECs. The potential of ANP to induce
an increase in superoxide generation could also be regarded
as a form of preconditioning leading to protection of ECs
against an inflammatory response. A similar observation was
reported in HUVECs after short-time treatment with H2O2.44
In conclusion, we describe here ANP as a novel endoge-
nous activator of Nox2-containing endothelial Nox, which
mediates anti-inflammatory actions by inducing formation of
ROS/superoxide. We showed that ANP enhances production
of ROS/superoxide in ECs in vitro and in intact blood vessels,
and we revealed that ANP activates Rac1. The Rac1-
dependent increase of superoxide formation via Nox2 and the
superoxide-activated JNK/AP-1 pathway were presented as
key events in the induction of MKP-1 by ANP (Figure 8).
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